Annual Drug Patent Expirations for ZYNRELEF+KIT
Zynrelef Kit is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.
This drug has seventy patent family members in twenty countries.
The generic ingredient in ZYNRELEF KIT is bupivacaine; meloxicam. One supplier is listed for this compound. Additional details are available on the bupivacaine; meloxicam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
